First Time Loading...
B

Bausch + Lomb Corp
NYSE:BLCO

Watchlist Manager
Bausch + Lomb Corp
NYSE:BLCO
Watchlist
Price: 14.01 USD -3.65%
Updated: May 2, 2024

Bausch + Lomb Corp
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bausch + Lomb Corp
Revenue Peer Comparison

Comparables:
OTC
Z
ZEN
COO

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
B
Bausch + Lomb Corp
NYSE:BLCO
Revenue
$4.1B
CAGR 3-Years
7%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Ocumetics Technology Corp
XTSX:OTC
Revenue
CA$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Z
Zentek Ltd
XTSX:ZEN
Revenue
CA$33.6k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ostrom Climate Solutions Inc
XTSX:COO
Revenue
CA$3.7m
CAGR 3-Years
19%
CAGR 5-Years
20%
CAGR 10-Years
-7%

Bausch + Lomb Corp
Revenue Breakdown

Breakdown by Geography
Bausch + Lomb Corp

Total Revenue: 4.1B USD
100%
United States And Puerto Rico: 1.9B USD
46.6%
Other: 655m USD
15.8%
China: 344m USD
8.3%
France: 210m USD
5.1%
Japan: 187m USD
4.5%
Germany: 147m USD
3.5%
United Kingdom: 121m USD
2.9%
Canada: 110m USD
2.7%
Russia: 106m USD
2.6%
Spain: 85m USD
2.1%
Italy: 82m USD
2%
Mexico: 68m USD
1.6%
Poland: 51m USD
1.2%
South Korea: 46m USD
1.1%
Show More
Show Less

Breakdown by Segments
Bausch + Lomb Corp

Total Revenue: 4.1B USD
100%
Product Sales: 4.1B USD
99.6%
Vision Care: 2.5B USD
61.3%
Devices: 1.7B USD
39.8%
Otc: 1.6B USD
38.9%
Surgical: 767m USD
18.5%
Pharmaceuticals: 618m USD
14.9%
Branded And Other Generics: 252m USD
6.1%
Other Revenues: 15m USD
0.4%
Show More
Show Less

See Also

What is Bausch + Lomb Corp's Revenue?
Revenue
4.1B USD

Based on the financial report for Dec 31, 2023, Bausch + Lomb Corp's Revenue amounts to 4.1B USD.

What is Bausch + Lomb Corp's Revenue growth rate?
Revenue CAGR 5Y
2%

Over the last year, the Revenue growth was 10%. The average annual Revenue growth rates for Bausch + Lomb Corp have been 7% over the past three years , 2% over the past five years .